CHDI Foundation, Inc. has extended its ongoing collaboration with Charles River Laboratories for an additional five years through 2019. The collaboration began in 2005 and is focused on discovering novel drugs for Huntington’s disease.   Under the collaboration, Charles River provides a full range of research activities and expertise in the neuroscience area for CHDI, including integrated biology and chemistry capabilities, complex primary neuronal assay development, high-content screening, frag...